46 related articles for article (PubMed ID: 6653892)
1. HBIG efficacy in preventing HBV infection in infants.
D'Elia R; Pornaro E; Gussetti N; Largajolli G
Dev Biol Stand; 1983; 54():377-81. PubMed ID: 6653892
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
[TBL] [Abstract][Full Text] [Related]
3. HBIG immunoprophylaxis of babies born to HBsAg carrier mothers.
Zanetti AR; Magliano EM; Tanzi E; Ferroni P; Pirovano G; Pizzocolo G; Pillan N; Zunin C
Dev Biol Stand; 1983; 54():383-9. PubMed ID: 6653893
[TBL] [Abstract][Full Text] [Related]
4. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
Gussetti N; Pornaro E; Largajolli G; D'Elia R
Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection.
Chang MH
Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
[TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
9. Passive-active immunoprophylaxis in newborns to HBsAg carrier mothers liguria--I.
Crovari P; Caffarena G; Coppola R; Di Pietro P; Gasparini R; Gelli GP; Icardi GC; Pantarotto MF
Boll Ist Sieroter Milan; 1984 Sep; 63(4):290-8. PubMed ID: 6542797
[TBL] [Abstract][Full Text] [Related]
10. HBIG prophylaxis for perinatal HBV infections--final report of the Taiwan trial.
Beasley RP; Hwang LY; Szmuness W; Stevens CE; Lin CC; Hsieh FJ; Wang KY; Sun TS
Dev Biol Stand; 1983; 54():363-75. PubMed ID: 6360754
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
Xia GL; Gong J; Wang JJ; Meng ZD; Jia ZY; Cao HL; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):362-5. PubMed ID: 12820927
[TBL] [Abstract][Full Text] [Related]
12. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
13. [Specific, passive prevention of hepatitis B perinatal transmission to infants born to mothers with HBs antigenemia].
Rybacka-Atamaniuk J
Pol Tyg Lek; 1991 Apr 1-15; 46(14-16):268-70. PubMed ID: 1669049
[TBL] [Abstract][Full Text] [Related]
14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection in allogeneic bone marrow transplantation.
Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
[TBL] [Abstract][Full Text] [Related]
16. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
17. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
Roche B; Samuel D; Feray C; Majno P; Gigou M; Reynes M; Bismuth H
Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106
[TBL] [Abstract][Full Text] [Related]
18. [A follow-up study on correlated factors for intrauterine infection of hepatitis B virus].
Liu ZH; Men K; Xu D
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):263-5. PubMed ID: 9812600
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N
Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152
[TBL] [Abstract][Full Text] [Related]
20. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
